Figure 2From: Substantially improved pharmacokinetics of recombinant human butyrylcholinesterase by fusion to human serum albuminClearance of BChE/hSA fusion protein produced in vitro (A) and a transgenically produced BChE preparation containing >70% tetramer (B) in juvenile pigs in vivo. Juvenile pigs were injected i.v. with the proteins and plasma BChE activity (%) above control (untreated pigs, ~1.6 unit/ml) was plotted versus time (hours) for each animal.Back to article page